MedPath

Emergent Biodefense Operations Lansing LLC

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

FDA:2

Drug Approvals

Tembexa

Approval Date
Feb 24, 2023
FDA

Tembexa

Approval Date
Feb 24, 2023
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.